000 01709 a2200481 4500
005 20250513040051.0
264 0 _c19930218
008 199302s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.90.2.457
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBetter, M
245 0 0 _aPotent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cJan 1993
300 _a457-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmino Acid Sequence
650 0 4 _aAntigen-Antibody Reactions
650 0 4 _aAntigens, CD
_ximmunology
650 0 4 _aBase Sequence
650 0 4 _aBinding, Competitive
650 0 4 _aCD5 Antigens
650 0 4 _aCell Line
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEscherichia coli
_xgenetics
650 0 4 _aGenetic Engineering
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fab Fragments
_xgenetics
650 0 4 _aImmunoglobulin Heavy Chains
_xgenetics
650 0 4 _aImmunotoxins
_xmetabolism
650 0 4 _aMolecular Sequence Data
650 0 4 _aRecombinant Fusion Proteins
_xgenetics
650 0 4 _aRicin
_xmetabolism
650 0 4 _aT-Lymphocytes
_xdrug effects
700 1 _aBernhard, S L
700 1 _aLei, S P
700 1 _aFishwild, D M
700 1 _aLane, J A
700 1 _aCarroll, S F
700 1 _aHorwitz, A H
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 90
_gno. 2
_gp. 457-61
856 4 0 _uhttps://doi.org/10.1073/pnas.90.2.457
_zAvailable from publisher's website
999 _c7677881
_d7677881